INTERNATIONAL PATENT: LAEKNA THERAPEUTICS SHANGHAI CO., LTD. FILES APPLICATION FOR "TRIAZINE COMPOUNDS AND THEIR USE AS USP1 INHIBITORS"

GENEVA, Jan. 27 -- LAEKNA THERAPEUTICS SHANGHAI CO., LTD. (5th Floor, No. 987, Cailun Road, Zhangjiang Hi-Tech ParkPudong New Area, Shanghai 201203) filed a patent application (PCT/CN2024/105716) for "TRIAZINE COMPOUNDS AND THEIR USE AS USP1 INHIBITORS" on Jul 16, 2024. With publication no. WO/2025/016381, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Jintao (5th Floor, No. 987, Cailun Road, Zhangjiang Hi-Tech ParkPudong New Area, Shanghai 201203), LI, Ming (5th Floor, No. 987, Cailun Road, Zhangjiang Hi-Tech Park...